Global Non-Hodgkin Lymphoma Therapeutics Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	174 Pages	TechNavio	February, 2023	INF17742854

Best Price Guarantee
Price	from $2,500
Length	174 Pages
Publisher	TechNavio
Published Date	February, 2023
SKU	INF17742854

Global Non-Hodgkin Lymphoma Therapeutics Market 2023-2027

Technavio has been monitoring the non-Hodgkin lymphoma therapeutics market and is forecast to grow by $5427.51 mn during 2022-2027, accelerating at a CAGR of 8.14% during the forecast period. Our report on the non-Hodgkin lymphoma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by recent approvals and strong pipeline, growing geriatric population, and special drug designations.

Technavio's non-Hodgkin lymphoma therapeutics market is segmented as below:

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy
Others

By Therapy

Immunotherapy
Targeted therapy
Chemotherapy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the research grants and funding as one of the prime reasons driving the non-Hodgkin lymphoma therapeutics market growth during the next few years. Also, growing awareness about cancer and increase in patient assistance programs and reimbursements will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the non-Hodgkin lymphoma therapeutics market covers the following areas:

Non-Hodgkin lymphoma therapeutics market sizing
Non-Hodgkin lymphoma therapeutics market forecast
Non-Hodgkin lymphoma therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-Hodgkin lymphoma therapeutics market vendors that include AstraZeneca Plc, Baxter International Inc., Bayer AG, BeiGene Ltd., Biogen Inc., Bristol Myers Squibb Co., Eisai Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Seagen Inc., Spectrum Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd. Also, the non-Hodgkin lymphoma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Global Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Distribution Channel
  - Table Executive Summary – Chart on Market Segmentation by Therapy
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2022
- Market outlook: Forecast for 2022-2027
  - Table Chart on Global - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Global - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Global Market: Year-over-year growth 2022-2027 (%)
  - Table Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Historic Market Size
- Global non-hodgkin lymphoma therapeutics market 2017 - 2021
  - Table Historic Market Size – Data Table on Global non-hodgkin lymphoma therapeutics market 2017 - 2021 ($ million)
- Therapy Segment Analysis 2017 - 2021
  - Table Historic Market Size – Therapy Segment 2017 - 2021 ($ million)
- Distribution channel Segment Analysis 2017 - 2021
  - Table Historic Market Size – Distribution channel Segment 2017 - 2021 ($ million)
- Geography Segment Analysis 2017 - 2021
  - Table Historic Market Size – Geography Segment 2017 - 2021 ($ million)
- Country Segment Analysis 2017 - 2021
  - Table Historic Market Size – Country Segment 2017 - 2021 ($ million)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2022 and 2027
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2022 and 2027
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2022 and 2027
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2022 and 2027
- Market condition
  - Table Chart on Market condition - Five forces 2022 and 2027
Market Segmentation by Distribution Channel
- Market segments
  - Table Chart on Distribution Channel - Market share 2022-2027 (%)
  - Table Data Table on Distribution Channel - Market share 2022-2027 (%)
- Comparison by Distribution Channel
  - Table Chart on Comparison by Distribution Channel
  - Table Data Table on Comparison by Distribution Channel
- Hospital pharmacy - Market size and forecast 2022-2027
  - Table Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
- Retail pharmacy - Market size and forecast 2022-2027
  - Table Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
- Online pharmacy - Market size and forecast 2022-2027
  - Table Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
- Others - Market size and forecast 2022-2027
  - Table Chart on Others - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Others - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Others - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Others - Year-over-year growth 2022-2027 (%)
- Market opportunity by Distribution Channel
  - Table Market opportunity by Distribution Channel ($ million)
Market Segmentation by Therapy
- Market segments
  - Table Chart on Therapy - Market share 2022-2027 (%)
  - Table Data Table on Therapy - Market share 2022-2027 (%)
- Comparison by Therapy
  - Table Chart on Comparison by Therapy
  - Table Data Table on Comparison by Therapy
- Immunotherapy - Market size and forecast 2022-2027
  - Table Chart on Immunotherapy - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Immunotherapy - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Immunotherapy - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Immunotherapy - Year-over-year growth 2022-2027 (%)
- Targeted therapy - Market size and forecast 2022-2027
  - Table Chart on Targeted therapy - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
- Chemotherapy - Market size and forecast 2022-2027
  - Table Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
- Market opportunity by Therapy
  - Table Market opportunity by Therapy ($ million)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2022-2027 (%)
  - Table Data Table on Market share by geography 2022-2027 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2022-2027
  - Table Chart on North America - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on North America - Market size and forecast 2022-2027 ($ million)
  - Table Chart on North America - Year-over-year growth 2022-2027 (%)
  - Table Data Table on North America - Year-over-year growth 2022-2027 (%)
- Europe - Market size and forecast 2022-2027
  - Table Chart on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Europe - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Asia - Market size and forecast 2022-2027
  - Table Chart on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Asia - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Rest of World (ROW) - Market size and forecast 2022- 2027
  - Table Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- US - Market size and forecast 2022-2027
  - Table Chart on US - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on US - Market size and forecast 2022-2027 ($ million)
  - Table Chart on US - Year-over-year growth 2022-2027 (%)
  - Table Data Table on US - Year-over-year growth 2022-2027 (%)
- UK - Market size and forecast 2022-2027
  - Table Chart on UK - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on UK - Market size and forecast 2022-2027 ($ million)
  - Table Chart on UK - Year-over-year growth 2022-2027 (%)
  - Table Data Table on UK - Year-over-year growth 2022-2027 (%)
- Germany - Market size and forecast 2022-2027
  - Table Chart on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Germany - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Germany - Year-over-year growth 2022-2027 (%)
- China - Market size and forecast 2022-2027
  - Table Chart on China - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on China - Market size and forecast 2022-2027 ($ million)
  - Table Chart on China - Year-over-year growth 2022-2027 (%)
  - Table Data Table on China - Year-over-year growth 2022-2027 (%)
- Canada - Market size and forecast 2022-2027
  - Table Chart on Canada - Market size and forecast 2022-2027 ($ million)
  - Table Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  - Table Chart on Canada - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Canada - Year-over-year growth 2022-2027 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ million)
Drivers, Challenges, and Trends
- Market drivers
  - Recent approvals and strong pipeline
  - Growing geriatric population
  - Special drug designations
- Market challenges
  - Adverse effects of available therapeutics
  - Limited access to treatment
  - Stringent regulations
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2022 and 2027
- Market trends
  - Research grants and funding
  - Growing awareness about cancer
  - Increase in patient assistance programs and reimbursements
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- AstraZeneca Plc
  - Table AstraZeneca Plc - Overview
  - Table AstraZeneca Plc - Product / Service
  - Table AstraZeneca Plc - Key news
  - Table AstraZeneca Plc - Key offerings
- BeiGene Ltd.
  - Table BeiGene Ltd. - Overview
  - Table BeiGene Ltd. - Business segments
  - Table BeiGene Ltd. - Key offerings
  - Table BeiGene Ltd. - Segment focus
- Biogen Inc.
  - Table Biogen Inc. - Overview
  - Table Biogen Inc. - Product / Service
  - Table Biogen Inc. - Key offerings
- Bristol Myers Squibb Co.
  - Table Bristol Myers Squibb Co. - Overview
  - Table Bristol Myers Squibb Co. - Product / Service
  - Table Bristol Myers Squibb Co. - Key news
  - Table Bristol Myers Squibb Co. - Key offerings
- Eisai Co. Ltd.
  - Table Eisai Co. Ltd. - Overview
  - Table Eisai Co. Ltd. - Business segments
  - Table Eisai Co. Ltd. - Key offerings
  - Table Eisai Co. Ltd. - Segment focus
- F. Hoffmann La Roche Ltd.
  - Table F. Hoffmann La Roche Ltd. - Overview
  - Table F. Hoffmann La Roche Ltd. - Business segments
  - Table F. Hoffmann La Roche Ltd. - Key news
  - Table F. Hoffmann La Roche Ltd. - Key offerings
  - Table F. Hoffmann La Roche Ltd. - Segment focus
- Gilead Sciences Inc.
  - Table Gilead Sciences Inc. - Overview
  - Table Gilead Sciences Inc. - Product / Service
  - Table Gilead Sciences Inc. - Key news
  - Table Gilead Sciences Inc. - Key offerings
- GlaxoSmithKline Plc
  - Table GlaxoSmithKline Plc - Overview
  - Table GlaxoSmithKline Plc - Business segments
  - Table GlaxoSmithKline Plc - Key offerings
  - Table GlaxoSmithKline Plc - Segment focus
- Johnson and Johnson Services Inc.
  - Table Johnson and Johnson Services Inc. - Overview
  - Table Johnson and Johnson Services Inc. - Business segments
  - Table Johnson and Johnson Services Inc. - Key news
  - Table Johnson and Johnson Services Inc. - Key offerings
  - Table Johnson and Johnson Services Inc. - Segment focus
- Merck KGaA
  - Table Merck KGaA - Overview
  - Table Merck KGaA - Business segments
  - Table Merck KGaA - Key news
  - Table Merck KGaA - Key offerings
  - Table Merck KGaA - Segment focus
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Seagen Inc.
  - Table Seagen Inc. - Overview
  - Table Seagen Inc. - Product / Service
  - Table Seagen Inc. - Key offerings
- Spectrum Pharmaceuticals Inc.
  - Table Spectrum Pharmaceuticals Inc. - Overview
  - Table Spectrum Pharmaceuticals Inc. - Product / Service
  - Table Spectrum Pharmaceuticals Inc. - Key offerings
- Teva Pharmaceutical Industries Ltd.
  - Table Teva Pharmaceutical Industries Ltd. - Overview
  - Table Teva Pharmaceutical Industries Ltd. - Business segments
  - Table Teva Pharmaceutical Industries Ltd. - Key news
  - Table Teva Pharmaceutical Industries Ltd. - Key offerings
  - Table Teva Pharmaceutical Industries Ltd. - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations